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ABSTRACT
The human Werner and Bloom syndromes (WS
and BS) are caused by deficiencies in the WRN
and BLM RecQ helicases, respectively. WRN,
BLM and their Saccharomyces cerevisiae
homologue Sgs1, are particularly active in vitro
in unwinding G-quadruplex DNA (G4-DNA), a fam-
ily of non-canonical nucleic acid structures
formed by certain G-rich sequences. Recently,
mRNA levels from loci containing potential
G-quadruplex-forming sequences (PQS) were
found to be preferentially altered in sgs1D mutants,
suggesting that G4-DNA targeting by Sgs1 directly
affects gene expression. Here, we extend these
findings to human cells. Using microarrays to
measure mRNAs obtained from human fibroblasts
deficient for various RecQ family helicases, we
observe significant associations between loci
that are upregulated in WS or BS cells and
loci that have PQS. No such PQS associations
were observed for control expression datasets,
however. Furthermore, upregulated genes in WS
and BS showed no or dramatically reduced
associations with sequences similar to PQS but
that have considerably reduced potential to form
intramolecular G4-DNA. These findings indicate
that, like Sgs1, WRN and BLM can regulate tran-
scription globally by targeting G4-DNA.
INTRODUCTION
In humans, deﬁciencies in the RecQ-family DNA helicases
WRN or BLM cause Werner or Bloom syndromes,
respectively. Werner syndrome (WS) is marked by prema-
ture features of aging, including graying and loss of hair,
skin atrophy, cataracts, arteriosclerosis, osteoporosis and
an increased incidence of certain cancers (1). Indeed,
expression proﬁling of human ﬁbroblasts has revealed
that loss of WRN results in global transcriptional
changes that resemble normal aging (2). Bloom
syndrome (BS) is marked by an increased incidence of
nearly all types of cancer, in addition to immune and
developmental abnormalities (3). WRN and BLM
function in multiple facets of DNA metabolism, including
replication, repair, recombination and telomere mainte-
nance (4,5). However, the understanding of how abroga-
tion of WRN or BLM function is translated into the
pathologies of WS or BS remains incomplete.
In yeast, genes that are repressed in sgs1D RecQ helicase
mutants are signiﬁcantly associated with transcription
units containing sequences with the potential to form
intramolecular G-quadruplexes (6). G-quadruplexes are
a family of DNA (G4-DNA) or RNA (G4-RNA) struc-
tures that form when guanine residues from one or more
nucleic acid strands form planar arrangements of four
guanines (G-quartets) via Hoogsteen hydrogen bonding.
These structures then stack to form G-quadruplexes,
which can be highly stable under physiological tempera-
ture, pH and salt conditions, and which can diﬀer from
one another based on strand number and polarity,
glycosidic bond angles, and loop sequence and topology
(7). The distribution of potential intramolecular
G-quadruplex-forming sequences (here referred to as
PQS) in the human genome has recently been described
(8–13). In addition, the formation of G-quadruplexes
in vivo has been clearly demonstrated both at telomeres
in S. lemnae and in human immunoglobulin class switch
recombination regions that have been transcribed in
Escherichia coli (14,15).
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G4-DNA in vitro, with a clear preference for this substrate
(16). Therefore, the preferentially altered expression
of PQS-containing genes observed in sgs1D mutants
suggests that Sgs1 modulates gene expression via direct
eﬀects on G4-DNA. WRN and BLM share with Sgs1
the propensity to unwind G4-DNA (16–18). All three of
the proteins possess a conserved RQC domain, which
binds G4-DNA with high aﬃnity (Kd 5nM) and thus
confers G4-selectivity to the helicases (19).
To test the hypothesis that altered gene expression in
WS and BS occurs preferentially at loci containing PQS,
as observed for sgs1D yeast, we compared expression
proﬁles of cultured normal human ﬁbroblasts with
those having mutations in WRN, BLM or RECQ4, the
latter encoding a third human RecQ helicase homo-
log, mutation of which causes Rothmund–Thompson
syndrome (RTS) (20,21). RECQ4 is an active DNA
helicase (22), but lacks an RQC domain and therefore is
not expected to target G4-DNA. In addition, if RECQ4
were to interact with G4-DNA, it would presumably do so
in a fashion diﬀerent from WRN and BLM. No gene
expression studies have been described for RTS or BS.
In the current study, we ﬁnd that gene expression is
considerably altered in WS and BS cells as compared
with normal and RTS cells. Moreover, upregulated
genes in WS and BS cells are signiﬁcantly enriched for
PQS. Importantly, there is no enrichment of PQS among
genes with increased expression in RTS cells. These results
represent the ﬁrst demonstration that loss of WRN and
BLM directly aﬀects expression of PQS-containing loci
genome-wide, and further suggest that this eﬀect is
directly mediated by G4-DNA in vivo.
MATERIALS AND METHODS
Cell culture conditions and media
Human ﬁbroblast cell strains (WS: AG05229, AG12795,
AG12797; BS: GM02932, GM03402, GM16891; RTS:
AG18371, AG18375, AG05013; Normal/Wild-type:
AG04054, AG06310, AG09975) were obtained from the
Coriell Repository (Camden, NJ, USA), from donors
matched for gender and of similar ages, and were at
similar passage levels (Supplementary Table S1). Cells
were cultured in MEM supplemented with Earle’s salts,
20% fetal bovine serum, 1x penicillin/streptomycin,
and 1x fungizone in 3% O2 at 37 C and harvested for
RNA extraction during active growth and at  80%
conﬂuence.
GeneChip microarray expression
Total RNA from the 12 ﬁbroblast cell strains was isolated
by extraction with TRIzol (Invitrogen) and puriﬁed using
the RNeasy system (Qiagen). Total RNA was ampliﬁed
by in vitro transcription using the Ovation RNA
Ampliﬁcation System V2 (NuGen). The resultant cDNA
was fragmented and labeled using the FL-Ovation
cDNA Biotin Module V2 (NuGen), and then puriﬁed
using QIAquick columns (Qiagen), as speciﬁed by the
Ovation System manual. Labeled probe was hybridized
to Aﬀymetrix U133A 2.0 GeneChips, and ultimately
scanned using an Axon GenePix array scanner. The
complete dataset is available on the Gene Expression
Omnibus (GEO) database http://www.ncbi.nlm.nih
.gov/geo/.
Statistical analysis of microarray expression experiment
The output ﬁles were normalized by Robust Multiarray
Average (RMA), using the R package GCRMA (23) and
gene expression levels were log2-transformed. The
R/Bioconductor package limma (24) was applied to rank
genes in order of evidence for diﬀerential expression of
WS, BS, and RTS versus wild-type simultaneously using
a P-value cut-oﬀ of 0.001. Hierarchical clustering
(complete linkage/Euclidean distance) and Principle
Component Analysis were applied to RMA-adjusted
log2 expression levels to examine similarities between
samples.
Identiﬁcation of PQS and overlap with diﬀerentially
expressed genes
Human genomic sequences (Release 18; without
repeat-masking) were downloaded from the UCSC
Genome Browser and scanned for PQS motifs, exactly
as described (8). Speciﬁcally, intramolecular PQS was
deﬁned as a string matching the regular expression
G3+N1–7G3+N1 7G3+N1 7G3+, where N1 7 represents
a loop region of any nucleotide sequence of length 1–7.
These motifs were then classiﬁed by the subgenic region in
which their centers reside, according to the Release 18
RefSeq annotations: (i) 50 ﬂank (1kb upstream of the tran-
scription start), (ii) 50 UTR, (iii) introns 1, 2 and 3, (iv) 30
UTR and (v) 30 ﬂank (1kb downstream of the transcript).
When appropriate, motifs were categorized into multiple
subgenic regions (e.g. in the case of overlapping tran-
scripts). In addition, motifs were further categorized
based on whether they are present on the sense or
anti-sense strands. Overlapping motifs were considered
to comprise a single motif, such that motifs describe
tracts of at least 4G-runs separated by loops of length
no greater than 7.
For each subgenic region, the motif density was
computed as the total number of motifs in the region
divided by the size of the region in kilo base pairs.
These densities were then averaged across all genes to
give a mean density for that region type. The genomic
density was computed as the number of motifs occurring
in the genome divided by the genome size in kilo base
pairs.
PQS was analyzed using the R/Bioconductor package
GOstats (25) to determine the signiﬁcance of their associ-
ations with diﬀerentially regulated probe sets, selected
using a P-value cutoﬀ of 0.01. Signiﬁcance was determined
by Fisher’s exact test, using a P-value cutoﬀ of 10
 4.
Overlap of pPQS control motifs with diﬀerentially
expressed genes
In order to control for non G4-DNA-related sequence
features such as GC-richness, we performed the above
expression-correlation analysis with two other types of
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dicted to form G-quadruplexes. The ﬁrst is the pattern
G3+N1–7G3+N1–7G3+ with the constraint that an
additional G3+ may not appear within eight
nucleotides on either side; this represents a putative
G-quadruplex-forming sequence with one G-run missing
(pPQS). The second control pattern matches sequences
that have an edit distance of up to two from PQS
motifs. This corresponds to a sequence that diﬀers from
the putative G-quadruplex-forming pattern by having
up to two nucleotide changes within the G-runs
(pPQS-mut2). In particular, pPQS-mut2 conforms to
the pattern G3+N1–7G3+N1;7G3+N1–7G3+, where at
least one, and maximally two, G-runs must be GHG or
where one G-run must be GHHG (where H is A, C or T).
RESULTS
Exploratory analysis of expression proﬁles of ﬁbroblasts
deﬁcient for RecQ family proteins
To examine diﬀerences in gene expression proﬁles among
samples, we made use of principal component analysis
(PCA) (Figure 1A) and hierarchical clustering (Figure
1B) (26) to analyze 12 expression datasets, including
three samples each for normal, WS, BS and RTS
(samples described in Supplementary Table S1).
Speciﬁcally, PCA was performed by using an orthogonal
linear transformation to simplify each complex expression
dataset to two simple numerical values that could be
graphically represented on a two-dimensional coordinate
graph such that the greatest variance lies on the ﬁrst axis
and the next greatest variance on the second axis.
Similarly, hierarchical clustering was achieved by parti-
tioning the datasets into subsets (clusters) as a function
of shared characteristics, here determined by Euclidean
distance measures over all probe sets. We found that
signal variations within the WS and BS groups were
each larger than those within the normal and RTS
samples. Furthermore, the normal and RTS samples clus-
tered together with one WS and one BS sample, while the
remaining four samples from the WS and BS groups
lay relatively far apart by both PCA and clustering
analyses. These ﬁndings indicate that (i) the expression
proﬁles of cells from normal and RTS individuals are
both similar to one another and relatively reproducible,
whereas (ii) loss of WRN or BLM helicase function can
produce more gene expression changes as compared with
loss of RECQ4.
Diﬀerentially expressed genes in WS, BS and RTS cells
To further assess gene expression changes, we determined
the number of gene probes diﬀerentially expressed in each
of the three mutant groups (WS, BS and RTS) as
compared with normal cells (Figure 2). These analyses
revealed that considerably more gene probes were
diﬀerentially expressed in the WS (up, n=764; down,
n=299; total, n=1063) or BS (up, n=867; down,
n=244; total, n=1111) than in the RTS cells (up,
n=113; down, n=153; total, n=264). In addition,
more probe sets were upregulated than downregulated in
both the WS and BS cells (72% and 75% upregulated,
respectively), while this bias was not observed in RTS
cells (42% upregulated). Furthermore, many diﬀerentially
expressed probe sets were speciﬁc to WS only (n=689) or
BS only (n=747). Taken together, these results suggest
that, with respect to changes in gene expression in
ﬁbroblasts, deﬁciencies of WRN, BLM and RTS might
have biological eﬀects that are both complex and
distinct from one another. For example, genes
commonly aﬀected in all three syndromes are
downregulated, though those speciﬁcally dysregulated in
WS and/or BS, but not RTS, tend to be upregulated.
Based on the lack of an RQC domain in the RECQ4
helicase, a potential explanation for the diﬀerent biologi-
cal eﬀects of these protein deﬁciencies on gene expression
is that loss of WRN or BLM function causes upregulation
of gene expression through dysregulation of G4-DNA,
while a G4-DNA-independent mechanism that is altered
similarly in all three diseases leads to the downregulation
of certain genes.
Figure 1. Multivariate analyses of gene expression data. (A) Principle
component analyses. Two-dimensional visualization of samples by the
ﬁrst two principal components (PC1 and PC2). (B) Average linkage
clustering of samples by Euclidean distance. The vertical axis (Height)
indicates the similarity between the clusters.
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To test whether the upregulation of genes observed in WS
or BS cells is related to PQS, a data set of human genes
containing PQS within diﬀerent subgenic regions was
compared with the sets of diﬀerentially expressed genes
(Figure 3A). The likelihood that the association between
PQS and altered gene expression is due to random
chance is indicated by a P-value based on the Fisher’s
exact test. Intramolecular PQS was deﬁned as
G3+N1-7G3+N1-7G3+N1-7G3+, exactly as described (8).
PQS predictions were performed for sequences on either
the sense or anti-sense strands and within individual
subgenic regions, including 1kb regions upstream and
downstream from transcription units, 50 and 30 UTRs,
and introns. The 1kb upstream region, here referred to
as ‘50 ﬂank’, corresponds to the region of high PQS
density previously identiﬁed within the promoters of
human genes (9). PQS density diﬀers according to
subgenic region (8–10,27) (Supplementary Table S3).
However, we chose to examine multiple regions because
PQS-related regulation by WRN or BLM need not corre-
late with regions having the highest PQS density. Indeed,
it was reported recently that upon expression of a selective
G4-DNA-binding single chain antibody in human cells,
there is preferential regulation of loci possessing PQS
near their transcription end sites (TESs), even though
PQS density around TESs is generally low (28).
Remarkably, we found that genes that are upregulated
in WS and BS cells correlate well with genes that are pre-
dicted to form intramolecular G-quadruplexes (P<10
 4
for the majority of subgenic regions). No such association
was observed for downregulated genes in WS or BS cells.
Further, there was no signiﬁcant enrichment of PQS in or
near genes that are upregulated in RTS samples, although
there was a weak association with the second intronic
region for downregulated genes. These results are consis-
tent with the fact that the WRN and BLM, but not
RECQ4, helicases have G-quadruplex-binding RQC
domains. In addition, PQS was compared with altered
gene expression in cultured ﬁbroblasts from individuals
with a genetic disorder unrelated to WS and BS, Setleis
syndrome (GEO ID number GSE16524) (29). As
expected, there was no association between PQS in the
majority of subgenic regions and gene expression
changes in Setleis syndrome, and only weak associations
for downregulated genes and PQS in the third intron and
30 UTR (P 10
 4; data not shown).
To control for the possibility that the association of
upregulated gene expression in WS and BS ﬁbroblasts
might simply be a function of a sequence feature
associated with PQS, such as GC-richness, and not
intramolecular G4-DNA forming potential per se, we per-
formed the above expression-correlation analysis with two
other types of sequence motifs, neither of which are pre-
dicted to form stable intramolecular G-quadruplexes.
First, we tested for associations with loci having only
partial PQS (pPQS) motifs conforming to the pattern
G3+N1 7G3+N1 7G3+ and lacking a fourth G3+
sequence within eight nucleotides of the pattern. Thus,
pPQS are highly similar to PQS, but are less likely to
form intramolecular G4-DNA. Gene expression was
compared with pPQS and while most pPQS-containing
regions showed no associations with upregulated loci,
pPQS within the 50 and 30 UTRs was weakly associated
with upregulated genes in BS (Figure 3B). However,
we note that, with respect to the 30 UTR, the
association of BS upregulated genes with bona ﬁde
G-quadruplex-forming sequences (PQS) was much more
signiﬁcant than the association with pPQS control
sequences (10
 11 versus 10
 4). Gene expression was also
compared with a second control data set comprising genes
containing sequences that diﬀer from the PQS pattern by
up to two nucleotides (pPQS-mut2) (Figure 3C). Similar
to the results for pPQS, the majority of gene regions con-
taining pPQS-mut2 showed no signiﬁcant associations
with upregulated loci in WS or BS cells, while weak asso-
ciations were observed for upregulated genes in BS and
control sequences in the 30 UTR and 30 ﬂank. As above,
actual PQS sequences in these regions show much more
signiﬁcant associations with BS upregulated loci as
compared with pPQS-mut2 control sequences (30 UTR,
10
 11 versus 10
 4;3 0 ﬂank, 10
 9 versus 10
 4). As an addi-
tional control, we also compared diﬀerentially expressed
genes in WS and BS with genes containing simple
tetranucleotide repeat sequences that are predicted not
to form stable G-quadruplexes ([AAAB]5o r9 , [AAGG]5
or 9, [AGAT]5o r9and [ATCC]5o r9 ) (30). As expected, no
signiﬁcant associations were found (all P-values>10
 3;
data not shown).
Previous analyses of PQS in the human genome have
revealed strand asymmetries within various subgenic loca-
tions (8,10,12,14). We therefore investigated whether the
Figure 2. Diﬀerentially expressed gene probes in RecQ
helicase-deﬁcient ﬁbroblast cell strains. (A) upregulated genes and (B)
downregulated genes. Indicated values are subsets of a total 22277 gene
probes.
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identiﬁed in the current study demonstrate strand bias.
Towards this end, we classiﬁed PQS motifs according
to strand, as well as subgenic region, and assessed
strand-speciﬁc PQS associations with altered gene expres-
sion using the Fisher’s exact test. Interestingly, the PQS
associations are similar for the anti-sense and sense
strands (Supplementary Table S2). This observed lack of
strand bias is also true for similar analyses involving pPQS
and pPQS-mut2 control sequences (Supplementary Tables
S4 and S5, respectively).
The similar patterns of altered gene expression in WS
and BS cells raised the question of how many diﬀerentially
expressed genes are shared by these two syndromes. When
all genes are considered, whether they contain PQS or not,
 20% of all upregulated genes in WS and BS are
shared (Supplementary Table S6). Interestingly, when
the analysis is restricted to targets with PQS, the overlap
improves for both the 30 ﬂank (WS) and 30 UTR (WS and
BS). These data, therefore, provide further evidence of the
relationship between G4-DNA and altered gene expres-
sion in WS and BS cells.
DISCUSSION
We have found highly signiﬁcant associations between
genes that have intramolecular PQS and those from
which transcripts accumulate in primary cultured
ﬁbroblasts from individuals with WS or BS. Further, the
current study is the ﬁrst report of PQS-associated changes
in global gene expression in the context of human genetic
disease. The preferential upregulation of gene expression
at loci with PQS in WS and BS cells, together with the
preference of the WRN and BLM helicases to unwind
G4-DNA in vitro, argues that the observed gene expres-
sion changes involve G4-DNA. Furthermore, there was
no such preferential regulation of PQS loci in RTS cells,
which have defects in the RECQ4 helicase. Because
RECQ4 lacks the RQC domain that enables WRN and
BLM to bind G4-DNA, there is no reason to expect
RECQ4 to have a preference for G4-DNA substrates,
consistent with our ﬁndings and supporting the speciﬁcity
of the PQS association in WS and BS. Although RQC
domains mediate the interaction of RecQ-family helicases
with G4-DNA, they are not generally required for all
helicases to unwind G-quadruplexes. For example, the
FANCJ helicase unwinds G4-DNA but does not possess
an RQC domain (31). So, while it is expected that
RECQ4, as a RecQ helicase, would require an RQC
domain for interaction with G4-DNA, we cannot
completely rule out a role for the protein at these struc-
tures. Nevertheless, if RECQ4 were to interact with
G4-DNA, it would do so in a RQC-independent
manner, suggesting that it might recognize diﬀerent G4
targets than WRN or BLM, or interact in a diﬀerent
fashion with the same targets. Additional studies will be
required to determine why RTS cells lack signiﬁcant
PQS-associated changes in gene expression, but the
simplest prediction is that RECQ4 lacks the same selectiv-
ity for G4-DNA as WRN and BLM. Concerning the asso-
ciation of gene expression changes and PQS in WS and BS
cells, an alternative to the proposed G4-DNA-dependent
mechanism is that these syndromes are associated with the
altered activity of transcription factors that bind duplex
DNA targets that, when present in tandem arrays, happen
to conform to the PQS pattern. Such an explanation,
however, is inconsistent with the lack of correlation
between gene expression changes and the partial PQS
patterns, both of which (pPQS and pPQS-mut2) would
still be predicted to bind  75% as many copies of such
transcription factors (as only one of four G-runs are
ablated in the partial PQS sequences). In addition, there
are also no known transcription factors that both bind
G-rich sequences and have altered activity in WS or BS.
Using the same or similar algorithms to the one we
employed to identify PQS, previous studies have found
Figure 3. Combined analysis of overlap signiﬁcance in the indicated
subgenic locations between diﬀerentially expressed genes and genes
with PQS or PQS-related motifs having much lower G4-DNA
forming potential (pPQS or pPQS-mut2). Values are given for associ-
ations with PQS (A), pPQS (B) and pPQS-mut2 (C). Signiﬁcance is
computed by one-sided Fisher’s test. Categorized by region, P-values
are colored to highlight signiﬁcant overlaps: white text within a black
background indicates a P-value lower than 10
 4. Black text within a
gray background indicates a P-value of intermediate signiﬁcance,
between 10
 4 and 10
 3.
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UTRs and ﬁrst introns of genes (9,10,12). Our ﬁndings are
consistent with these results, but genes diﬀerentially
expressed in WS and BS cells do not show greater enrich-
ment within these subgenic locations, as compared with
others. A possible explanation for this observation is that
WRN and BLM target only genes with particular kinds of
G4-DNA structures (e.g. with particular loop sequences
or topologies), which are then dysregulated in their
absence. It is also possible that only a subset of the G4
structures targeted by WRN and BLM aﬀect gene expres-
sion and the distribution of such structures is not identical
to the distribution of PQS overall. Such a case would be
similar to the situation in yeast, where the most PQS lies
upstream of promoters, but the strongest association with
altered gene expression in sgs1 mutants is with PQS
within the transcription unit (6). In particular, we ﬁnd
that genes upregulated in WS and BS cells are enriched
for PQS in essentially all subgenic regions, including
upstream promoter regions, introns and downstream
regions ﬂanking the TES (transcription end site)
(Figure 3A and Supplementary Table S2). While it is
unclear how modulation of G4 structures in these partic-
ular regions results in diﬀerential gene expression, we
speculate that G4-DNA in diﬀerent subgenic regions can
have diﬀerent mechanistic eﬀects on transcriptional regu-
lation. More speciﬁcally, it is possible that G4-DNA in
intronic regions and regions proximal to the TES can
aﬀect the eﬃciency of transcriptional elongation
and/or termination, whereas similar structures within
promoter-proximal regions aﬀect transcriptional initiation
(9,10). As noted earlier, the intersection of diﬀerentially
expressed genes in WS and BS shows enrichment for genes
with PQS in the 30 ﬂank and 30 UTR (Supplementary
Table S6), suggesting that genes with G4-DNA near the
TES are regulated by a similar mechanism in both WS and
BS cells.
We further ﬁnd that while there is some overlap between
genes that are dysregulated in WS and BS, the majority of
diﬀerentially expressed genes are unique to one or the
other syndrome. For PQS loci, this diﬀerence might be
explained by the WRN and BLM helicases acting on dif-
ferent types of G4-DNA structures located in diﬀerent
genes, or a diﬀerential activity at the same structures.
An intriguing possibility is that such diﬀerences might
contribute to the unique pathologies of these disorders,
but additional studies will be required to test this
speculation.
Our ﬁndings also indicate that the PQS-related mecha-
nism likely operates via transcriptional regulation, rather
than by altered mRNA stability, as PQS on sense and
anti-sense strands have similar associations with
upregulated mRNA levels in WS and BS cells.
Furthermore, WRN and BLM, despite being able to
unwind RNA–DNA and DNA–DNA duplexes, have no
known RNA–RNA unwinding activity (32,33). As a
result, these helicases are unlikely to process G4-RNA,
indicating that the simplest mechanism by which gene
expression changes are engendered in WS and BS cells is
through modulation of G4-DNA in genes, themselves,
and not altered stability of the resulting transcripts.
However, as our studies only examined mRNA abun-
dance, they do not rule out the possibility of additional
eﬀects of PQS on RNA processing or translation in WS
and BS.
We found previously that Saccharomyces cerevisiae cells
lacking the Sgs1 RecQ helicase, which possesses an RQC
domain and actively unwinds G4-DNA, also have
quadruplex-related changes in gene expression. Although
our new ﬁndings extend the association from yeast to
human cells, there are important diﬀerences between the
two sets of ﬁndings. sgs1D mutants downregulate expres-
sion of loci having quadruplex-forming potential within
their transcription units, whereas WS and BS cells
upregulate loci with PQS, and particularly in the case of
BS, this association extends to several subgenic regions
including those upstream and downstream of transcrip-
tion units. There are several possible explanations for
these diﬀerences. One is that transcriptional regulatory
factors that bind or are excluded by G4-DNA could
vary between yeast and human cells, and thus the regula-
tory consequences of G4-DNA formation would depend
upon the particular milieu of such factors. Another is that
instead of global diﬀerences in regulatory factors, the local
contexts in which G4-DNA can form might vary between
organisms. For example, G-quadruplex forming sequences
targeted by WRN and BLM in humans might tend to lie
within regions where repressors (e.g. nucleosomes) bind
duplex DNA and are excluded by G4-DNA formation
leading to increased transcription, whereas those
targeted by Sgs1 in yeast might instead reside at locations
that impede transcription upon G4-DNA formation.
A third possibility is that the spectrum of particular
G4-DNA structures formed might also vary between
organisms, perhaps also distinguishing how loci with
quadruplex-forming potential could be diﬀerentially
regulated in yeast and man. Additional studies will be
required to determine if the repression of gene expression
in sgs1D mutants versus the activation of gene expression
in WS and BS cells reﬂects diﬀerent regulatory functions
of G4-DNA or diﬀerent eﬀects of the yeast and human
RecQ proteins.
Previously published studies have found sequences with
the capacity to form G4-DNA in several human
cancer-related genes (hif1- , ret, vegf, k-ras, c-kit, c-myc,
bcl2, pdgfa) (34–44). In our datasets, the majority of these
factors are not diﬀerentially expressed upon loss of WRN
or BLM helicase activity (not shown). However, expres-
sion of vegf, c-kit, c-myc and pdgfa was found to be
downregulated in WS and BS cells (data not shown), con-
sistent with previous reports that stabilization of G4 struc-
tures in these genes results in inhibition of their expression
(34,38,40–44), and notable given that G4-DNA recognized
by WRN or BLM in wild-type cells is likely stabilized in
WS and BS cells. That expression of the majority of the
indicated genes is unchanged in WS and BS cells suggests
that not all G4-DNA elements are aﬀected by WRN or
BLM. In addition, while both our data and previous
studies suggest that vegf, c-kit, c-myc and pdgfa transcrip-
tion is inhibited by stabilization of G4-DNA, the majority
of PQS-associated expression changes in WS and BS
cells comprise upregulation events, indicating that the
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observed for the speciﬁc examples listed above is not, in
this case, representative of the global trend following gross
stabilization of G4-DNA (i.e. upregulation). We also note
that previous ﬁndings support both upregulation and
downregulation of gene expression via G4-DNA related
mechanisms. For example, in human cells following treat-
ment with the G4-binding ligand TmPyP4 or expression of
a single-chain antibody speciﬁc for G4-DNA, expression
from PQS loci was altered preferentially, with some loci
upregulated and others downregulated (28,45).
As mentioned above, owing to the fact that the WRN
and BLM helicases have been shown to bind and unwind
G-quadruplexes, it is likely that G4-DNA levels are
increased in their absence. Although we consider it less
likely, we note that if their helicase activities are inhibited
by other factors (e.g. p53) (46), it is possible that WRN
and BLM might instead promote G4-DNA formation and
thus levels could diminish in their absence. Altered levels
of G4-DNA might aﬀect transcription directly via changes
in chromatin. For example, in yeast and human cells,
reduced levels of nucleosome occupancy are associated
with PQS (6,47,48), and thus higher levels of G4-DNA
could be associated with elevated levels of transcription
in WS or BS cells. Alternatively, increased G4-DNA
levels in WS or BS cells might result in the creation
binding sites for transcriptional activators that bind
G4-DNA (49–52) or the destruction of binding sites for
repressors that bind duplex DNA. Yet another possibility
is that the lack of binding of WRN or BLM to G4-DNA
simply relieves occlusion of transcriptional activators,
without a concomitant change in G4-DNA levels.
Future studies will be aimed at discriminating between
these possibilities. Regardless of the speciﬁc mechanism
being employed, however, it is clear that the
transcriptional program is altered in cells lacking WRN
and BLM and that this alteration is associated, in part,
with DNA sequences having intramolecular G-quadruplex
forming potential.
Beyond any signiﬁcance our ﬁndings might have for the
pathogenesis of WS and BS, they provide important data
supporting previous observations indicating roles for
G4-DNA in transcriptional regulation in human cells.
Earlier studies have relied on mutagenesis of PQS
elements to indicate the importance of the element in reg-
ulation or on the activity of small molecule ligands that
bind and stabilize G4-DNA selectively to impact regula-
tion via PQS elements (28,34,35,40,42,45,53). In the ﬁrst
set of cases, it is diﬃcult to completely exclude the possi-
bility that mutagenesis not only perturbs G4-DNA
forming potential but also the association of canonical
duplex-DNA binding transcription factors, whereas in
the second set it is possible that the ligands induce
G4-DNA that would not otherwise form naturally, thus
altering expression via perturbation of natural mecha-
nisms. In the case of PQS-associated upregulation of
gene expression in WS and BS, the changes reﬂect the
loss of G4-DNA processing helicases, thus providing
support for the idea that G4-DNA does function in
natural gene regulation, at least in the setting of disease.
Furthermore, because our analyses were performed
genome-wide, they allowed for the repeated testing of
the association for each of the thousands of
PQS-containing genes, thus providing statistical support
of the connection between PQS and altered gene expres-
sion in WS and BS. It will be a challenge for future studies
to dissect the precise mechanisms underlying the
associations.
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